Finance News - Fda

All U.S. UK Canada Australia Europe India Global Crypto

No results found

Type at least 2 characters to search

Loading tags...

No matching tags found

Filter by:

Any time Past hour Past 24 hours Past week Past month Past year

All Sources ABC News Business BBC Business Business Insider Markets City A.M. CNBC Business CoinDesk Coinpedia Cointelegraph Crypto News CryptoSlate Decrypt Economic Times Markets Euronews Business Financial Post Top Stories Financial Times Globe and Mail Investing Investing.com Global Mkts Investopedia Kiplinger MarketWatch MarketPulse MarketWatch Top Stories Quartz Sky News Money Sydney Morning Herald Biz TechCrunch Fintech The Block The Guardian – Business WSJ Markets News

All Access Types Free Limited Free Subscription Required

Category Fda

Date Past month

CNBC Business • 02/13/2026 • Free

What signal Lilly sends by stockpiling its GLP-1 weight loss pills ahead of FDA approval

Lilly’s accumulation of GLP-1 weight loss pills prior to FDA approval indicates strategic preparation for potential high demand, which could significa...

Read Full Article →

MarketWatch Top Stories • 02/11/2026 • Free

Moderna’s work developing seasonal vaccines is ‘risky’ under current FDA, analyst says

Moderna’s inability to secure FDA review for its flu vaccine could delay its seasonal vaccine rollout, potentially impacting its revenue growth and in...

Read Full Article →

CNBC Business • 02/10/2026 • Free

Moderna says FDA refuses to review its application for experimental flu shot

The FDA's refusal to review Moderna's mRNA-1010 application may delay the company's potential revenue growth from the experimental flu shot and impact...

Read Full Article →

CNBC Business • 02/09/2026 • Free

FDA says Novo Nordisk's TV ad for obesity pill includes 'false or misleading' claims

The FDA's request to halt misleading advertisements may impact Novo Nordisk's marketing strategy and potentially affect the sales performance of its o...

Read Full Article →

MarketWatch Top Stories • 02/06/2026 • Free

Novo Nordisk stock climbs out of hole on FDA chief’s threat to block Hims and Hers pill

Novo Nordisk's stock rise reflects investor optimism about the FDA's potential support, which could strengthen the company's market position against r...

Read Full Article →

Sydney Morning Herald Biz • 01/16/2026 • Free

ASX Runners of the Week: Zelira, Linq, Dalaroo and Osteopore

Zelira Therapeutics secured a $33 million investment aimed at accelerating the development and regulatory review of its autism treatment, highlighting...

Read Full Article →

Price Alerts

Sign in to create alerts

Finance News - Fda

What signal Lilly sends by stockpiling its GLP-1 weight loss pills ahead of FDA approval

Moderna’s work developing seasonal vaccines is ‘risky’ under current FDA, analyst says

Moderna says FDA refuses to review its application for experimental flu shot

FDA says Novo Nordisk's TV ad for obesity pill includes 'false or misleading' claims

Novo Nordisk stock climbs out of hole on FDA chief’s threat to block Hims and Hers pill

ASX Runners of the Week: Zelira, Linq, Dalaroo and Osteopore

Featured Sources

What is your interest today?

Sign in to continue

Weekly limit reached

Export limit reached

Historical lookups used

Extended Charts - Pro Feature

Cloud Export - Pro Feature

Finance News - Fda

What signal Lilly sends by stockpiling its GLP-1 weight loss pills ahead of FDA approval

Moderna’s work developing seasonal vaccines is ‘risky’ under current FDA, analyst says

Moderna says FDA refuses to review its application for experimental flu shot

FDA says Novo Nordisk's TV ad for obesity pill includes 'false or misleading' claims

Novo Nordisk stock climbs out of hole on FDA chief’s threat to block Hims and Hers pill

ASX Runners of the Week: Zelira, Linq, Dalaroo and Osteopore

Featured Sources

What is your interest today?

Format Settings

Language

Localized Format

Decimal Format